Clinical Trial Update: Rivastigmine Study in Adolescents With Down Syndrome [Phase 1, Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 1/2 clinical trial of rivastigmine in adolescents with Down syndrome. Results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Exelon (rivastigmine)

Snippet

Sponsor: Duke University | Conditions: Down Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-03-12